Liver injury with novel oral anticoagulants: assessing post‐marketing reports in the US Food and Drug Administration adverse event reporting system

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2125|80|2|285-293

ISSN： 0306-5251

Source： BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol.80, Iss.2, 2015-08, pp. : 285-293

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Association rule mining in the US Vaccine Adverse Event Reporting System (VAERS)

By  

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 24, Iss. 9, 2015-09 ,pp. : 922-933

John Wiley & Sons Inc

Access to resources Recommend Favorite

Off‐label use of nicardipine as tocolytic and acute pulmonary oedema: a post‐marketing analysis of adverse drug reaction reports in EudraVigilance

By  

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 24, Iss. 11, 2015-11 ,pp. : 1220-1224

John Wiley & Sons Inc

Access to resources Recommend Favorite

An Information Technology Architecture for Drug Effectiveness Reporting and Post-Marketing Surveillance

By  

International Journal of Healthcare Information Systems and Informatics (IJHISI), Vol. 2, Iss. 3, 2007-07 ,pp. : 65-80

IGI Global_journal

Access to resources Recommend Favorite

Acquired haemophilia and the New Oral Anticoagulants (NOACs): coincidence or drug‐induced adverse event?

By  

HAEMOPHILIA, Vol. 21, Iss. 6, 2015-11 ,pp. : e496-e497

John Wiley & Sons Inc

Access to resources Recommend Favorite

Paraesthesia after Local Anaesthetics: An Analysis of Reports to the FDA Adverse Event Reporting System

By  

BASIC AND CLINICAL PHARMACOLOGY & TOXICOLOGY (ELECTRONIC), Vol. 117, Iss. 1, 2015-07 ,pp. : 52-56

John Wiley & Sons Inc

Access to resources Recommend Favorite